Lawrence N. Tanenbaum, M.D., Appointed to Chair the CureMetrix Strategic Medical and Scientific Advisory Board
LA JOLLA, CA, UNITED STATES, June 18, 2019 /EINPresswire.com/ -- CureMetrix®, a healthcare technology company that develops computer-aided detection (CAD) software integrated with artificial intelligence (AI), announced that Lawrence N. Tanenbaum, M.D., FACR, will join the company to chair its Strategic Medical and Scientific Advisory Board. As Chair, Dr. Tanenbaum will focus on creating clinical and industry value and utility with CureMetrix products that are trusted and accepted by the medical …